Riskpilot← Back to searchSign inGet full accessZINOLI AB
ABActiveOrg 5590361217Knektagatan 1Medical specialists activities · NACE 8622Est. 20152 employees
Revenue 2025
SEK 1,9M
-1% vs 2024
EBITDA margin
7.6%
+44% vs 2024
Equity ratio
58.2%
Financial strength
Net profit 2025
SEK 57K
+192% vs 2024
| Revenue | SEK 1,9M | -1% |
| EBITDA | SEK 142K | +44% |
| Net profit | SEK 57K | +192% |
| Total assets | SEK 504K | -30% |
| Equity | SEK 294K | -40% |
| Employees | 2 | — |
Legal name
ZINOLI AB
Org number
5590361217
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 november 2015
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom sjukvård, hälsokost, apotek, utbildning och fastighet samt därmed förenlig verksamhet.
Address
Knektagatan 1
Email
isam.alkarkhi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 948 | 1 979 | 2 180 | 1 898 | 1 875 |
| Staff expenses | — | −1 507 | −1 560 | −1 585 | −1 570 |
| EBITDA | 264 | 228 | 396 | 99 | 142 |
| Depreciation & amort. | −39 | −39 | −45 | −65 | −62 |
| EBIT | 225 | 190 | 351 | 34 | 80 |
| Net financials | −1 | −1 | 1 | 1 | 2 |
| Profit before tax | 225 | 189 | 353 | 35 | 82 |
| Tax | −54 | −44 | −85 | −15 | −25 |
| Net profit | 171 | 145 | 268 | 20 | 57 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 002 | 864 | 946 | 724 | 504 |
| Equity | 805 | 699 | 717 | 486 | 294 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 198 | 165 | 230 | 238 | 211 |
| Total debt | 198 | 165 | 230 | 238 | 211 |
EBITDA margin
7.6%
This company
15.8%
Market median
-52% vs market
20212025
Equity ratio
58.2%
This company
38.2%
Market median
+52% vs market
20212025
Return on equity
19.5%
This company
18.4%
Market median
+6% vs market
20212025
Net profit margin
3.0%
This company
8.1%
Market median
-63% vs market
20212025
Asset turnover
3.72×
This company
1.12×
Market median
+232% vs market
20212025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ZINOLI AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Enas Rasim Ismail Ismail | Deputy Board Member | 0 companies |
| Isam Muhammed Hasan Arif Al-Karkhi | Board of Directors | 0 companies |